Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.600
-0.050 (-3.03%)
Jun 27, 2025, 2:26 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $267.32 million as of June 27, 2025. Its market cap has decreased by -72.50% in one year.
Market Cap
267.32M
Enterprise Value
130.85M
Revenue
27.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.60
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 267.32M, a decrease of -50.35%. That is a compound annual growth rate of -13.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 27, 2025 | 273.46M | -15.82% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.60B |
Elite Pharmaceuticals | 779.84M |
Veradigm | 764.23M |
Nika Pharmaceuticals | 708.22M |
Tian'an Technology Group | 628.15M |
Glass House Brands | 459.12M |
American Oncology Network | 422.12M |
CytoDyn | 375.37M |